Data on the safety and tolerability of revefenacin, in patients with moderate to very severe chronic obstructive pulmonary disease

This article contains information on the experimental design and methods on how the safety and tolerability data concerning patients with moderate to very severe chronic obstructive pulmonary disease (COPD) were obtained. This is in addition to our original research article. [1] We have also provide...

Descripción completa

Detalles Bibliográficos
Autores principales: Donohue, James, Kerwin, Edward, Sethi, Sanjay, Haumann, Brett, Pendyala, Srikanth, Dean, Lorna, Barnes, Chris N., Moran, Edmund J., Crater, Glenn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Medicine and Dentistry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6744553/
https://www.ncbi.nlm.nih.gov/pubmed/31534988
http://dx.doi.org/10.1016/j.dib.2019.104277

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6744553/
https://www.ncbi.nlm.nih.gov/pubmed/31534988
http://dx.doi.org/10.1016/j.dib.2019.104277

Ejemplares similares